Development of cytotoxicity-sensitive human cells using overexpression of long non-coding RNAs
JOURNAL OF BIOSCIENCE AND BIOENGINEERING
Authors: Tani, Hidenori; Torimura, Masaki
Abstract
Biosensors using live cells are analytical devices that have the advantage of being highly sensitive for their targets. Although attention has primarily focused on reporter gene assays using functional promoters, cell viability assays are still efficient. We focus on long non-coding RNAs (IncRNAs) that are involved in the molecular mechanisms associated with responses to cellular stresses as a new biological material. Here we have developed human live cells transfected with IncRNAs that can be used as an intelligent sensor of cytotoxicity for a broad range of environmental stresses. We identified three IncRNAs (GAS5, IDI2-AS1, and SNHG15) that responded to cycloheximide in HEK293 cells. Overexpression of these IncRNAs sensitized human cells to cell death in response to various stresses (cycloheximide, ultraviolet irradiation, mercury II chloride, or hydrogen peroxide). In particular, dual IncRNA (GAS5 plus ID12-AS1, or GASS plus SNHG15) overexpression sensitized cells to cell death by more cellular stresses. We propose a method for highly sensitive biosensors using overexpression of IncRNAs that can potentially measure the cytotoxicity signals of various environmental stresses. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.
Body Weight Telemetry Is Useful to Reduce Interdialytic Weight Gain in Patients with End-Stage Renal Failure on Hemodialysis
TELEMEDICINE AND E-HEALTH
Authors: Neumann, Claas L.; Wagner, Fabian; Menne, Jan; Brockes, Christiane; Schmidt-Weitmann, Sabine; Rieken, Eike M.; Schettler, Volker; Hagenah, Gerrit C.; Matzath, Stephan; Zimmerli, Lukas; Haller, Hermann; Schulz, Egbert G.
Abstract
Lacking compliance with liquid intake restrictions is one of the major problems in patients on hemodialysis and causes an increased mortality. In 120 patients on hemodialysis with an average interdialytic weight gain (IWG) exceeding 1.5 kg on at least 2 days during the 4 weeks preceding the intervention, the effect of telemetric body weight measurement (TBWM) on IWG, ultrafiltration rate, and blood pressure was evaluated over a period of 3 months. Patients of the telemetric group (TG) were supplied with automatic scales, which transferred the weight via telemetry on a daily basis. In the case of IWG of more than 0.75 kg/24 h, a telephonic contact was made as required, and in the case of an IWG of more than 1.5 kg, telephonic contacting was obligatory along with the advice of a liquid intake restriction to 0.5 L/day until the next dialysis. The patients of the control group (CG) received standard treatment without telemetric monitoring. We examined specific data of the second interdialytic interval (IDI2) and the average within 1 week. The average difference of IWG between TG and CG was not significant before the start of the study but 0.2 kg (p = 0.027) (IDI2)/0.27kg (p = 0.001) (WP) at the end of the study, respectively. The average difference in the ultrafiltration rate within 1 week was 19.0 mL/h (p = 0.282) (IDI2)/8.2 mL/h (p = 0.409) before the start of the study but 28.4 mL/h (p = 0.122) (IDI2)/30.9 mL/h (p = 0.004) at the end of the study, respectively. Thus, TBWM is a feasible method for optimizing the IWG and reducing the ultrafiltration rate.